For a recurrent, MSI-H endometrial cancer, do you usually treat with Pembrolizumab alone or in combination with Lenvatinib?

1 Answers

Mednet Member

Gynecologic Oncology · Bronx Lebanon Hospital Center

Alone.

For a recurrent, MSI-H endometrial cancer, do you usually treat with Pembrolizumab alone or in combination with Lenvatinib? | Mednet